SlideShare uma empresa Scribd logo
1 de 55
Presented by :- Dr Mangilal

Moderator:- Dr AvnishBhardwaj
Introduction
 CARDIAC disease in pregnancy remains an
 important etiology of maternal ,fetal morbidity and
 mortality.

 Mitral stenosis is the most commonly acquired valve
 lesion encountered in pregnant women and is almost
 invariably caused by RHD.

 Pregnancy and the peripartum period worsen
 symptoms of cardiac disease.
Presenting Complaints
 A 37 year old woman presented at 28 weeks
  gestational age with inability to lie and became
  dyspneic even when speaking (class IV).
 Had complete placenta previa, possible placenta
  accreta.
Past History
 Patient complained of dyspnea with moderate exertion
  before pregnancy( class II )
 Past medical history – No history of TB, DM
  , HTN, Asthma,convulsion,chest pain
 Drug history – no history of any drug allergy.
 Family history- not significant
Obs. history
 Gravida 2, Para 1
 Previous h/o Cesarean section delivery 16 yr earlier
Clinical examination
 Physical examination revealed an arterial blood pressure of
  102/60 mmHg,
 Regular heart rate of 108 beats/min,
 Respiratory rate of 22 breaths/min.
 There were diastolic(grade 2) and holosystolic( grade 3)
  apical murmurs.
 The patient’s lungs were clear to auscultation
       bilaterally, and she had mild pedal edema.
 Her symptoms improved with heart rate control
   using 25 mg metoprolol orally twice daily.
Investigation
   Electrocardiogram showed
    sinus tachycardia and left
    atrial enlargement.
   Transthoracic
    echocardiogram revealed
    moderate to severe mitral
    stenosis, moderate to severe
    mitral regurgitation, and
    moderate pulmonary
    hypertension with estimated
    pulmonary artery systolic
    pressure of 54 mmHg. There
    was moderate tricuspid
    regurgitation.
   Left and right ventricular
    systolic function were
    normal.
PROVISIONAL DIAGNOSIS-
PREGNANCY WITH MS
Management
 Cesarean section was planned at 36 weeks
 gestational age in a cardiac operating room with
 cardiopulmonary bypass capabilities on standby.
 Prophylaxis against acid aspiration, 30 ml sodium
  bicitrate was administered orally in the holding area.
 Patient was positioned in the left uterine displacement
 Initial systemic arterial blood pressure was 125/65
  (mean 76)mmHg. Her heart rate was 105 beats/min.
 Remifentanil (0.2 ǔgm/kg/min) was started to
  attenuate the sympathetic response to laryngoscopy
  and intubation.
Induction
     Etomidate, and Succinylcholine was used for relaxant administered in
    a rapid sequence fashion.
Maintenance
 Remifentanil infusion(0.05– 0.1ug /kg/min),
      Low level of Isoflurane(less than 0.5 minimum alveolar
    concentration),
      Vecuronium for muscle relaxant.
      Higher doses of inhalational agents were avoided to prevent uterine
    atony.
      Depth of anesthesia was monitored using bispectral index values
    from 40–60 were maintained during the intraoperative period.
    The patient was ventilated using 100% oxygen to maintain
    normocarbia.
 Intra op monitoring by TEE ,Colour doppler
 Three-dimensional ultrasound reconstruction of the
  mitral valve showed significant commissural
  fusion(mitral valve area 1.4cm2).
 Cesarean section was performed without
  complications.
 After delivery, 40 U oxytocin was administered
  intravenously in 2 hr.
Initially monitored in the operating room
  after extubation to ensure normocarbia and stable
  pulmonary artery pressures.
 Then transferred to the cardiac care unit for postoperative
  monitoring.
 The patient was discharged from the cardiac care
  unit on postoperative day 1 and from the hospital on
  postoperative day 5.
 She underwent mitral valve repair and tricuspid
   valve annuloplasty 4 months later.
Heart disease with pregnancy
 Epidemiology - incidence of cardiac disease in
  pregnant

     0.2% to 3% of pregnancies are complicated by maternal heart
      disease in developed countries

     Heart diseases are still the second most common non obstetrical
      cause of maternal mortality

    Rheumatic heart disease accounts for majority of cases (~ 75%) in
    India while congenital heart disease are most common in developed
    countries
  -- Mitral stenosis is the most commonly acquired valve lesion
        in pregnant women and is almost caused by RHD.
.


RHD
     Highly prevalent in developing countries.


     India, the prevalence of RHD is 6:1,000 ( school-
     aged children)

     Carditis occurs in 30–80% of patients with acute
     rheumatic fever, and at least 60% of untreated patients
     develop chronic RHD.
Physiological changes - Consideration In Pregnancy

    The most important changes in cardiac function occurs in
    the first 8 weeks of pregnancy with maximum changes at 28
    weeks

↓   Vascular resistance
↓   Blood pressure
↑   Heart rate              ↑ Stroke volume       ↑ CO
↑   Blood volume                                   30% - 50%
The fall in the peripheral resistance is about 20-30% at
 21-24 weeks & returns to normal at term. This fall is due to

1. The trophoblastic erosion of endometrial vessels,
   the placental bed serves as a large arteriovenous shunt
   causing lowered systemic vascular resistance

2. There is physiological vasodilatation which is believed to
   be secondary to endothelial prostacyclin and circulating
   progesterone.

3 .Anemia decreases blood viscosity with resultant decrease
  in systemic vascular resistance.
Physiological changes during pregnancy
Physiological changes during labour
Risk of haemodynamic stress
 At the time of labor and delivery, pain and anxiety
  increase catecholamine release with resultant
  increases in heart rate, arterial blood pressure, and
  cardiac output.
 Auto-transfusion of up to 500 ml with each
  contraction , increases preload and, hence cardiac
  output.
 After delivery, there is an additional increase in venous
  return as a result of auto-transfusion from the
  contracting uterus as well as from the loss of foetal
  compression of the inferior vena cava.
Features in Pregnancy which can
  mimic cardiac disease
1. Dyspnoea - due to hyperventilation, elevated
  diaphragm.
2. Pedal Edema
3. Cardiac impulse- Diffused and shifted laterally due to
  elevated diaphragm.
4. Jugular veins may be distended and JVP raised.
5. Systolic ejection murmurs along the left sternal
  border occur in 96% of pregnant women and are
  believed to be caused by increased flow across the
  aortic and pulmonary valves.
Criteria to diagnose cardiac disease
during pregnancy:


 1.Presence of diastolic murmurs.
 2.Systolic murmurs of severe intensity (grade III)
 3.Unequivocal enlargement of heart (X-ray)
 4.Presence of severe arrythmias, atrial fibrillation
     or flutter .
Risk of cardiovascular complications during
pregnancy
                            Risk of
                        cardiovascular
                        complications
                       during pregnancy




                                                  High risk
    Low risk             Intermediate risk
                                                     of
        of                      of
                                               complications
complications (≤ 1%)   complications (5-15%)
                                               or death (≥25%)
 Low risk of complications (≤ 1%):
    Corrected tetralogy of fallot
    Atrial septal defect
    Ventricular septal defect
    Patent ductus arteriosus
    Mild pulmonic or tricuspid valve disease
    Mitral stenosis (NYHA class I, II)
    Mild regurgitant valve lesion
    Bioprosthetic valve
    Compensated heart failure (NYHA class I, II)
 Intermediate risk of complications (5-15%):
    Mechanical valve prosthesis
    Aortic stenosis (mild to moderate)
    Mitral stenosis with atrial fibrillation
    Mitral stenosis (NYHA class III, IV)
    Uncorrected cyanotic congenital heart disease
     (tetralogy of fallot)
    Uncorrected coarctation of the aorta
    Previous myocardial infarction
 High risk of complications or death (≥25%):
   Pulmonary hypertension (severe)
   Eisenminger syndrome
   Marfan disease with aortic root involvement
   Peripartum cardiomyopathy
   Severe aortic stenosis
   NYHA class IV heart failure
The indications for Termination of
pregnancy
1.   Eisenmenger’s syndrome.
2. Marfan’s syndrome with aortic involvement
3. Pulmonary hypertension.
4. Coarctation of aorta with valvular involvement.
      Termination should be done before 12
      weeks of pregnancy.
The New York Heart Association (NYHA) Grading of
 functional capacity of the heart:
            No functional limitation of activity    Symptoms with extra
CLASS I                                             ordinary physical work.



            Mild limitation of physical activity.   Symptoms with ordinary
CLASS II                                            physical work


            Marked limitation of physical           Symptoms with less than
CLASS III   activity                                ordinary physical work



CLASS IV    Severe limitation of physical           Symptoms at rest
            activity
Prognosis depends on the functional status

 NYHA classes I and II lesions
    usually do well during pregnancy and have a
    favorable prognosis (mortality rate of <1%).
 NYHA classes III and IV -mortality rate of 5% to
15%.
  These patients should be advised against
becoming pregnant.
Risk factors for cardiac failure during pregnancy

 Infection
 Anemia
 Obesity
 Hypertension
 Hyperthyroidism
 Multiple pregnancy
Etiology
    The main cardiac diseases occuring with
    pregnancy are

   Rheumatic heart disease
   Congenital heart disease
   Coronary heart disease
   Cardiomyopathy
Mitral stenosis
   Most common manifestation of rheumatic heart
    disease

   Incidence: ~ 90%

   Symptoms develop ~ 30 years after rheumatic fever

   Symptoms occur mitral valve orifice <2cm² (normal:
    4-6 cm²)
Mitral Stenosis:Pathophysiology
 Normal valve area: 4-6 cm2
 Mild mitral stenosis:
    MVA 1.5-2.5 cm2
    Minimal symptoms
 Mod. mitral stenosis
    MVA 1.0-1.5 cm2 usually does not produce symptoms at rest
 Severe mitral stenosis
    MVA < 1.0 cm2
Mitral Stenosis: Symptoms
 Breathlessness
 Fatigue
 Oedema, ascites
 Palpitation
 Haemoptysis
 Cough
 Chest pain
 mitral facies or malar flush
 Symptoms of thromboembolic complications (e.g. stroke, ischaemic
  limb)
 Worsened by conditions that cardiac output.
   ◦ Exertion,fever, anemia, tachycardia,, pregnancy, thyrotoxicosis
Signs of Mitral Stenosis
Palpation:
 Small volume pulse
 Tapping apex-palpable S1
 Palpable S2

 Atrial fibrillation
 Signs of raised pulmonary capillary pressure
    Crepitations, pulmonary oedema, effusions
 Signs of pulmonary hypertension
    RV heave, loud P2


Auscultation:
 Loud S1
 S2 to OS interval inversely proportional to severity
 Diastolic rumble: length proportional to severity
 In severe MS with low flow- S1, OS & rumble may be inaudible
Mitral Stenosis: Physical Examination



         S1                  S2    OS                   S1

• First heart sound (S1) is loud and snapping

• Opening snap (OS)

• Low pitch diastolic rumble at the apex

• Pre-systolic accentuation (esp. if in sinus rhythm)
Mitral Stenosis:
Complications

 Atrial dysrrhythmias
 Systemic embolization (10-25%)
    ◦ Risk of embolization is related to, age, presence of atrial
       fibrillation, previous embolic events
   Congestive heart failure
   Pulmonary infarcts (result of severe CHF)
   Hemoptysis
     ◦ Massive: 20 to ruptured bronchial veins (pulmonary HTN)
     ◦ Streaking/pink froth: pulmonary edema, or infection
   Endocarditis
   Pulmonary infections
Mitral Stenosis: Investigations
CXR
ECG
Echo
Mitral stenosis:CXR
                       The cardiac size is Unequivocal
                       1. the left atrial appendage is
                          prominent (LAA).
                         2. Main pulmonary artery
                          (MPA) segment is just outside
                          the left border, indicating
                          pulmonary hypertension.
                         3. The enlargement of left
                          pulmonary artery (LPA) and
                          right pulmonary artery (RPA)
                          are just modest, if at all.
                         4. The horizontal fissure is
                          visible, indicating collection of
                          edema fluid in the fissure.
                         5.The aortic knuckle (Ao) is also
                          seen well.
Mitral Stenosis:ECG
 LAE
 RVH
 Premature contractions
 Atrial flutter and/or fibrillation
      freq. in pts with mod-
     severe MS for several years       No P waves .
    A fib develops in    30% to
                                        rhythm is irregularly irregular
     40% of patients with
     symptoms                           right ventricular hypertrophy.
                                        Right axis deviation and deep S
                                       waves in the lateral leads.
                                        Combination of atrial fibrillation
                                       and right ventricular hypertrophy
                                       suggests mitral stenosis.
Mitral Stenosis: Role of
Echocardiography
  Diagnosis of Mitral Stenosis
  Assessment of hemodynamic severity
     ◦ mean gradient, mitral valve area, pulmonary artery
       pressure
    Assessment of right ventricular size and function.
    Assessment of valve morphology to determine
     suitability for percutaneous mitral balloon valvuloplasty
    Diagnosis and assessment of concomitant valvular lesions
    Reevaluation of patients with known MS with changing
     symptoms or signs.
Management
Mitral Stenosis:Therapy
 Medical
    Diuretics for LHF/RHF
    Anticoagulation: In Atrial Fibrillation
    AF requires aggressive treatment with digoxin and β-blockers . If
       pharmacotherapy fails, cardioversion should be performed. After
       cardioversion bed rest in left lateral position and diuretics should
       be given to ameliorates pulmonary oedema.
      Endocarditis prophylaxis
      β -blockers used to prevents tachycardia.
      Propanolol can be administered without any adverse effect on
       foetus or neonate
      Atenolol should be avoided in the early stages of pregnancy
       and only given with caution in the later stages because of its
       association with fetal growth retardation
Surgical management
     » Before pregnancy- if significant MS is recognised before pregnancy :
                         Surgery is recommended



            Mitral commisurotomy            Mitral valve replacement –
                 is preferred               Bioprosthetic valve is preferred

      » During pregnancy-
1.   Palliative Mitral Valvotomy : temporarily delays progression of MS and may
     enable successful completion of pregnancy. Best time is in 2nd trimester.
2.   Mitral commisurotomy : in case of severe symptoms it can be performed at
     any stage of gestation.
3.   Balloon Mitral Valvuloplasty : it is safe and effective in women with pliable
     valve .This circumvents open heart surgery and risks of anaesthesia and
     surgery for mother and foetus.
Anaesthetic Goals:
    Prevention of pain
    Avoid tachycardia (diastolic filling time further
     decreased)

    Events that increase the pulmonary vascular resistance like
     hypoxaemia, hypercarbia and acidosis should be avoided


     Avoid increases in blood volume (result in pulmonary
      edema)
     Avoid rapid and severe drop in SVR (compensatory
      increase in HR can lead to further decompensation)
     Immediate treatment of acute atrial fibrillation
The main principles of management with regard
to valvular heart disease in Pregnancy
• Early identification of the disease, and the assessment of the severity of the
lesion.

• High-risk lesions, for either mother or fetus, should be managed in a high
care environment where invasive monitoring is possible, both pre- and post
delivery.
• Regional anaesthesia techniques in labour are an attractive option, and
may be employed with good outcomes in many patients.
• Carefully titrated epidural anaesthesia for labour is associated with less
sympathetic blockade than spinal or epidural anaesthesia for caesarean
delivery.
• Severe mitral or aortic stenosis, or any valvular heart condition associated
with pulmonary oedema or heart failure, are contraindications to
regional anaesthesia.
Anaesthetic Options
VAGINAL DELIVERY :

   The role of the anaesthesiologist begins by providing good labour
    analgesia.

   Epidural anaesthesia is recommended, unless obstetrically
    contraindicated.

   Caesarean section is indicated for OBSTETRIC REASONS ONLY.

   Tachycardia, secondary to labour pain, increases flow across the mitral
    valve, producing sudden rises in left atrial pressure, leading to acute
    pulmonary oedema. This tachycardia is averted by epidural analgesia
    without significantly altering the patient haemodynamics.
Mitral stenosis : Regional
Anaesthesia
 I stage of labour : MS does not change management-adequate
  analgesia is essential to minimize tachycardia. Epidural analgesia is
  effective. Adequate hydration should be maintained. Intrathecal opioid
  such as Fentanyl 25 μg produces good analgesia without major
  haemodynamic changes.
 II stage of labour : Minimize maternal expulsive
  efforts, allowing fetal descent to be accomplished by uterine
  contractions. This is to avoid the deleterious effects of the Valsalva
  maneuver, which causes an undesirable increase in venous return.
 Intrathecal opioid with low dose LA can be given for analgesia and
  anaesthesia. The 2nd stage should be cut short by instrumentation.
 LA to provides perineal anaesthesia
• CSE : intrathecal opioid +/- small dose of LA followed by slow epidural
infusion of a dilute solution of LA +/- opioid. (0.125% bupivacaine +
2µg/ml fentanyl).
• Epinephrine should be avoided as it may induce tachycardia.
• Phenylephrine- vesopressor of choice (no tachycardia)

• Invasive cardiac monitoring like radial artery cannulation and
pulmonary catheter are beneficial in assessing the cardiac
output, pulmonary artery pressure and for guiding fluid and drug
therapy, especially in NYHA III and IV patients.

• Foetal heart rate monitoring should be carried out during all stages of
labour.

• Pulse oximetry monitoring is mandatory.

• Supplementary epidural anaesthesia can be maintained throughout the
immediate post-partum period and the catheter left in situ could provide
anaesthesia for immediate or post-partum tubal sterilization.
CAESAREAN-SECTION
 General anaesthesia NYHA class 3 and 4 patients .


    Regional anaesthesia is preferred over general anaesthesia
    in NYHA class 1 and2 patients
    –   Regional : Spinal & Epidural

     Epidural anaesthesia - preferred over spinal anaesthesia :
   More predictability and control over hemodynamic changes.
   maintains systemic vascular resistance.
   gradual onset of sympathetic block
   Slower induction of anaesthesia and ensures maternal hemodynamic stability.





    Mitral stenosis:GA

   General anaesthesia has the disadvantage of increased Pulmonary Arterial
    pressure and tachycardia during laryngoscopy and tracheal intubation.
   Premedication : sedative and anxiolytics are avoided.
   Only counseling done to alleviate the anxiety.
   Preoxygenation:done with 100% o2 for 5 min.
   Induction :Inj. Thiopentone 3-4 mg/kg
   Intubation: Inj.succinylcholine 1-1.5mg/kg
   Maintained with opioids, neuromuscular blockers, nitrous oxide, and oxygen.
   A beta-adrenergic receptor antagonist,
    fentanyl, I.v xylocard should be administered before or during the induction of
    anaesthesia to blunt intubation response.
   The adverse effects of positive-pressure ventilation on the venous return may
    ultimately leads to cardiac failure.
Continued……
    Tachycardia inducing drugs like
    atropine, ketamine, pancuronium and meperidine, should be
    totally avoided.
   Esmolol has a rapid onset and short duration of action, it is a better
    choice in controlling tachycardia.

    Modified rapid sequence induction using etomidate, remifentanyl and
    succinylcholine is an ideal choice in tight stenosis with pulmonary
    hypertension.
    General anesthesia provides the advantages of definitive airway
    control and the ability to use transesophageal echocardiographic
    monitoring throughout the procedure.

    Higher doses of inhalational agents should be avoided to prevent uterine
    atony.

•Emergence must be carefully controlled to ensure avoidance of
tachycardia
Continued……
 Diuretics should also be used cautiously because
    hypovolemia can impair fetal blood supply
   Reversal: Avoid tachycardia, extubation is done when
    patient is fully awake.
    After delivery oxytocin should be administered as
    intravenous infusion preferably slowly. Stat i.v dosing
    should be avoided
    These Patients are at risk for haemodynamic
    compromise and pulmonary oedema during
    postpartum period,so require ICU care.
   For postoperative analgesia :I.V opioid or NSAIDS
Conclusion
 Irrespective of the mode of delivery and anaesthetic technique, these
    patients are at a great risk of haemodynamic stress due to
    autotransfusion of blood from the uterus. This may lead to pulmonary
    hypertension, pulmonary oedema and cardiac failure.
    Therefore, intensive monitoring and therapy should be continued till
    the haemodynamic parameters return to normal.

 As a rule, regurgitant valvular lesions are far better tolerated in
    pregnancy than are stenotic lesions.
.
 Patients with severe symptomatic valvular heart disease should ideally
  be counselled against pregnancy.
 In the event of pregnancy, early consultation between obstetrician and
  anaesthesiologist allows for planning with regards to both the timing of
  delivery and optimal analgesia/ anaesthesia.
Caeserean section complicated by mitral stenosis

Mais conteúdo relacionado

Mais procurados

ANESTHESIA FOR TOF SURGERY
ANESTHESIA FOR TOF SURGERYANESTHESIA FOR TOF SURGERY
ANESTHESIA FOR TOF SURGERYRaju Jadhav
 
Interscalene & supraclavicular nerve blocks
Interscalene  & supraclavicular nerve blocksInterscalene  & supraclavicular nerve blocks
Interscalene & supraclavicular nerve blocksDavis Kurian
 
DIABETES AND ITS ANAESTHETIC IMPLICATIONS
DIABETES AND ITS ANAESTHETIC IMPLICATIONSDIABETES AND ITS ANAESTHETIC IMPLICATIONS
DIABETES AND ITS ANAESTHETIC IMPLICATIONSSelva Kumar
 
Anaesthesia for cardiac patient undergoing non cardiac surgery
Anaesthesia for cardiac patient undergoing non cardiac surgeryAnaesthesia for cardiac patient undergoing non cardiac surgery
Anaesthesia for cardiac patient undergoing non cardiac surgeryDhritiman Chakrabarti
 
Mitral stenosis with pregnancy
Mitral stenosis with pregnancy Mitral stenosis with pregnancy
Mitral stenosis with pregnancy Ankita Patni
 
Anaesthetic considerations for laser surgery
Anaesthetic  considerations for  laser  surgeryAnaesthetic  considerations for  laser  surgery
Anaesthetic considerations for laser surgeryAnamika yadav
 
Long case pregnancy with mitral stenosis sandeep kumar kar
Long case pregnancy with mitral stenosis sandeep kumar karLong case pregnancy with mitral stenosis sandeep kumar kar
Long case pregnancy with mitral stenosis sandeep kumar karisakakinada
 
Double Lumen Endobronchial Tubes ppt
Double Lumen Endobronchial Tubes pptDouble Lumen Endobronchial Tubes ppt
Double Lumen Endobronchial Tubes pptImran Sheikh
 
Ischemic heart disease and anesthetic management
Ischemic heart disease and anesthetic managementIschemic heart disease and anesthetic management
Ischemic heart disease and anesthetic managementkrishna dhakal
 
Perioperative Arrythmias and management
Perioperative Arrythmias and managementPerioperative Arrythmias and management
Perioperative Arrythmias and managementDr Nandini Deshpande
 
Anesthesia Management in Aortic Regurgitation
Anesthesia Management in Aortic RegurgitationAnesthesia Management in Aortic Regurgitation
Anesthesia Management in Aortic RegurgitationDr. Harshil Joshi
 
Low flow Anaesthesia & Gas Monitoring
Low flow Anaesthesia & Gas MonitoringLow flow Anaesthesia & Gas Monitoring
Low flow Anaesthesia & Gas MonitoringKalpesh Shah
 
Anaesthesia for congenital heart disease
Anaesthesia for congenital heart diseaseAnaesthesia for congenital heart disease
Anaesthesia for congenital heart diseaseDhritiman Chakrabarti
 
Anaesthesia for neurosurgery
Anaesthesia for neurosurgeryAnaesthesia for neurosurgery
Anaesthesia for neurosurgerySiti Azila
 
Anesthetic management in copd
Anesthetic management in copdAnesthetic management in copd
Anesthetic management in copdDr.RMLIMS lucknow
 
Anesthesia for coronary artery bypass grafting
Anesthesia for coronary artery bypass graftingAnesthesia for coronary artery bypass grafting
Anesthesia for coronary artery bypass graftingaparna jayara
 

Mais procurados (20)

ANESTHESIA FOR TOF SURGERY
ANESTHESIA FOR TOF SURGERYANESTHESIA FOR TOF SURGERY
ANESTHESIA FOR TOF SURGERY
 
Interscalene & supraclavicular nerve blocks
Interscalene  & supraclavicular nerve blocksInterscalene  & supraclavicular nerve blocks
Interscalene & supraclavicular nerve blocks
 
DIABETES AND ITS ANAESTHETIC IMPLICATIONS
DIABETES AND ITS ANAESTHETIC IMPLICATIONSDIABETES AND ITS ANAESTHETIC IMPLICATIONS
DIABETES AND ITS ANAESTHETIC IMPLICATIONS
 
Baska mask
Baska mask Baska mask
Baska mask
 
Anaesthesia for cardiac patient undergoing non cardiac surgery
Anaesthesia for cardiac patient undergoing non cardiac surgeryAnaesthesia for cardiac patient undergoing non cardiac surgery
Anaesthesia for cardiac patient undergoing non cardiac surgery
 
Mitral stenosis with pregnancy
Mitral stenosis with pregnancy Mitral stenosis with pregnancy
Mitral stenosis with pregnancy
 
Anaesthetic considerations for laser surgery
Anaesthetic  considerations for  laser  surgeryAnaesthetic  considerations for  laser  surgery
Anaesthetic considerations for laser surgery
 
Long case pregnancy with mitral stenosis sandeep kumar kar
Long case pregnancy with mitral stenosis sandeep kumar karLong case pregnancy with mitral stenosis sandeep kumar kar
Long case pregnancy with mitral stenosis sandeep kumar kar
 
Double Lumen Endobronchial Tubes ppt
Double Lumen Endobronchial Tubes pptDouble Lumen Endobronchial Tubes ppt
Double Lumen Endobronchial Tubes ppt
 
Ischemic heart disease and anesthetic management
Ischemic heart disease and anesthetic managementIschemic heart disease and anesthetic management
Ischemic heart disease and anesthetic management
 
Perioperative Arrythmias and management
Perioperative Arrythmias and managementPerioperative Arrythmias and management
Perioperative Arrythmias and management
 
Geriatric anaesthesia
Geriatric anaesthesiaGeriatric anaesthesia
Geriatric anaesthesia
 
Anaesthesia for LSCS
Anaesthesia for LSCSAnaesthesia for LSCS
Anaesthesia for LSCS
 
Anesthesia Management in Aortic Regurgitation
Anesthesia Management in Aortic RegurgitationAnesthesia Management in Aortic Regurgitation
Anesthesia Management in Aortic Regurgitation
 
Low flow Anaesthesia & Gas Monitoring
Low flow Anaesthesia & Gas MonitoringLow flow Anaesthesia & Gas Monitoring
Low flow Anaesthesia & Gas Monitoring
 
ASRA Guidelines
ASRA GuidelinesASRA Guidelines
ASRA Guidelines
 
Anaesthesia for congenital heart disease
Anaesthesia for congenital heart diseaseAnaesthesia for congenital heart disease
Anaesthesia for congenital heart disease
 
Anaesthesia for neurosurgery
Anaesthesia for neurosurgeryAnaesthesia for neurosurgery
Anaesthesia for neurosurgery
 
Anesthetic management in copd
Anesthetic management in copdAnesthetic management in copd
Anesthetic management in copd
 
Anesthesia for coronary artery bypass grafting
Anesthesia for coronary artery bypass graftingAnesthesia for coronary artery bypass grafting
Anesthesia for coronary artery bypass grafting
 

Destaque

mitral stenosis AHA guidlines 2014
mitral stenosis AHA guidlines 2014mitral stenosis AHA guidlines 2014
mitral stenosis AHA guidlines 2014Basem Enany
 
Mitral stenosis in pregnancy
Mitral stenosis in pregnancyMitral stenosis in pregnancy
Mitral stenosis in pregnancyMashfiqul Hasan
 
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...Ankur Khandelwal
 
Anaesthesia for functional neurosurgery
Anaesthesia for functional neurosurgeryAnaesthesia for functional neurosurgery
Anaesthesia for functional neurosurgeryDhritiman Chakrabarti
 
PERCUTANEOUS TREATMENT STRATEGIES OF VALVULAR HEART DISEASE
PERCUTANEOUS TREATMENT STRATEGIES OF VALVULAR HEART DISEASEPERCUTANEOUS TREATMENT STRATEGIES OF VALVULAR HEART DISEASE
PERCUTANEOUS TREATMENT STRATEGIES OF VALVULAR HEART DISEASEPraveen Nagula
 
Assessment of airway
Assessment of airwayAssessment of airway
Assessment of airwayWesam Mousa
 
Anaesthesia for robotic cardiac surgery
Anaesthesia for robotic cardiac surgeryAnaesthesia for robotic cardiac surgery
Anaesthesia for robotic cardiac surgeryDhritiman Chakrabarti
 
Airway management in for seadtion
Airway management in for seadtionAirway management in for seadtion
Airway management in for seadtionmoutasem al mashour
 
Alternative technique of intubation retromolar, retrograde, submental and oth...
Alternative technique of intubation retromolar, retrograde, submental and oth...Alternative technique of intubation retromolar, retrograde, submental and oth...
Alternative technique of intubation retromolar, retrograde, submental and oth...Dhritiman Chakrabarti
 

Destaque (20)

mitral stenosis AHA guidlines 2014
mitral stenosis AHA guidlines 2014mitral stenosis AHA guidlines 2014
mitral stenosis AHA guidlines 2014
 
Mitral stenosis
Mitral stenosisMitral stenosis
Mitral stenosis
 
Mitral stenosis
Mitral stenosisMitral stenosis
Mitral stenosis
 
Mitral stenosis
Mitral stenosisMitral stenosis
Mitral stenosis
 
Mitral stenosis in pregnancy
Mitral stenosis in pregnancyMitral stenosis in pregnancy
Mitral stenosis in pregnancy
 
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...
 
Breathing systems
Breathing systemsBreathing systems
Breathing systems
 
Anaesthesia for functional neurosurgery
Anaesthesia for functional neurosurgeryAnaesthesia for functional neurosurgery
Anaesthesia for functional neurosurgery
 
Epilepsy and anaesthesia
Epilepsy and anaesthesiaEpilepsy and anaesthesia
Epilepsy and anaesthesia
 
Icp monitoring seminar
Icp monitoring seminarIcp monitoring seminar
Icp monitoring seminar
 
PERCUTANEOUS TREATMENT STRATEGIES OF VALVULAR HEART DISEASE
PERCUTANEOUS TREATMENT STRATEGIES OF VALVULAR HEART DISEASEPERCUTANEOUS TREATMENT STRATEGIES OF VALVULAR HEART DISEASE
PERCUTANEOUS TREATMENT STRATEGIES OF VALVULAR HEART DISEASE
 
Assessment of airway
Assessment of airwayAssessment of airway
Assessment of airway
 
Anesthesiology Information
Anesthesiology InformationAnesthesiology Information
Anesthesiology Information
 
Anaesthesia for robotic cardiac surgery
Anaesthesia for robotic cardiac surgeryAnaesthesia for robotic cardiac surgery
Anaesthesia for robotic cardiac surgery
 
Female reproductive system
Female reproductive systemFemale reproductive system
Female reproductive system
 
OPCAB
OPCABOPCAB
OPCAB
 
Airway management in for seadtion
Airway management in for seadtionAirway management in for seadtion
Airway management in for seadtion
 
Anaesthesia in Diabetic patient
Anaesthesia in Diabetic patientAnaesthesia in Diabetic patient
Anaesthesia in Diabetic patient
 
Alternative technique of intubation retromolar, retrograde, submental and oth...
Alternative technique of intubation retromolar, retrograde, submental and oth...Alternative technique of intubation retromolar, retrograde, submental and oth...
Alternative technique of intubation retromolar, retrograde, submental and oth...
 
Obstetricanesthesia(1)
Obstetricanesthesia(1)Obstetricanesthesia(1)
Obstetricanesthesia(1)
 

Semelhante a Caeserean section complicated by mitral stenosis

Heart disease in pregnancy
Heart disease in pregnancyHeart disease in pregnancy
Heart disease in pregnancyNishant Thakur
 
Cardiac disease in pregnancy mar 2020
Cardiac disease in pregnancy mar 2020Cardiac disease in pregnancy mar 2020
Cardiac disease in pregnancy mar 2020mahmoodayub2
 
Cardiac disease in pregnancy mar 2020
Cardiac disease in pregnancy mar 2020Cardiac disease in pregnancy mar 2020
Cardiac disease in pregnancy mar 2020mahmoodayub2
 
Medical Complication Of Pregnancy
Medical Complication Of PregnancyMedical Complication Of Pregnancy
Medical Complication Of PregnancyDeep Deep
 
Cardiac diseases in pregnancy2
Cardiac diseases in pregnancy2Cardiac diseases in pregnancy2
Cardiac diseases in pregnancy2Arya Anish
 
Heart disease during pregnancy
Heart disease during pregnancyHeart disease during pregnancy
Heart disease during pregnancyOsama Khalil
 
complex medical disorders in pregnancy
 complex medical disorders in pregnancy  complex medical disorders in pregnancy
complex medical disorders in pregnancy partha sarathi roy
 
Pregnancy and heart disease copied by prof. Samir Rafla
Pregnancy and heart disease copied by prof. Samir RaflaPregnancy and heart disease copied by prof. Samir Rafla
Pregnancy and heart disease copied by prof. Samir RaflaAlexandria University, Egypt
 
Cardiac diseases complicating pregnancy
Cardiac diseases  complicating pregnancyCardiac diseases  complicating pregnancy
Cardiac diseases complicating pregnancyArya Anish
 
CARDIAC DISEASE IN PREGNANCY.pptx
CARDIAC DISEASE IN PREGNANCY.pptxCARDIAC DISEASE IN PREGNANCY.pptx
CARDIAC DISEASE IN PREGNANCY.pptxSrishtiGupta304
 
Cardiovascular Diseases on Pregnancy
Cardiovascular Diseases on PregnancyCardiovascular Diseases on Pregnancy
Cardiovascular Diseases on Pregnancypogisurabaya
 
cardiac disease in pregnancy
cardiac disease in pregnancycardiac disease in pregnancy
cardiac disease in pregnancyBalkeej Sidhu
 

Semelhante a Caeserean section complicated by mitral stenosis (20)

Heart disease in pregnancy
Heart disease in pregnancyHeart disease in pregnancy
Heart disease in pregnancy
 
Heart disease in pregnancy
Heart disease in pregnancy Heart disease in pregnancy
Heart disease in pregnancy
 
Cardiac disease in pregnancy mar 2020
Cardiac disease in pregnancy mar 2020Cardiac disease in pregnancy mar 2020
Cardiac disease in pregnancy mar 2020
 
Cardiac disease in pregnancy mar 2020
Cardiac disease in pregnancy mar 2020Cardiac disease in pregnancy mar 2020
Cardiac disease in pregnancy mar 2020
 
Cardiac Diseases in Pregnancy pptx
Cardiac Diseases in Pregnancy pptxCardiac Diseases in Pregnancy pptx
Cardiac Diseases in Pregnancy pptx
 
Medical Complication Of Pregnancy
Medical Complication Of PregnancyMedical Complication Of Pregnancy
Medical Complication Of Pregnancy
 
Cardiac diseases in pregnancy2
Cardiac diseases in pregnancy2Cardiac diseases in pregnancy2
Cardiac diseases in pregnancy2
 
Dhana presentation
Dhana presentationDhana presentation
Dhana presentation
 
Heart disease during pregnancy
Heart disease during pregnancyHeart disease during pregnancy
Heart disease during pregnancy
 
complex medical disorders in pregnancy
 complex medical disorders in pregnancy  complex medical disorders in pregnancy
complex medical disorders in pregnancy
 
Pregnancy and heart disease copied by prof. Samir Rafla
Pregnancy and heart disease copied by prof. Samir RaflaPregnancy and heart disease copied by prof. Samir Rafla
Pregnancy and heart disease copied by prof. Samir Rafla
 
Congenital heart disease
Congenital heart diseaseCongenital heart disease
Congenital heart disease
 
Cardiac diseases complicating pregnancy
Cardiac diseases  complicating pregnancyCardiac diseases  complicating pregnancy
Cardiac diseases complicating pregnancy
 
CARDIAC DISEASE IN PREGNANCY.pptx
CARDIAC DISEASE IN PREGNANCY.pptxCARDIAC DISEASE IN PREGNANCY.pptx
CARDIAC DISEASE IN PREGNANCY.pptx
 
12774872.ppt
12774872.ppt12774872.ppt
12774872.ppt
 
HEART DISEASE & PREGNANCY.pptx
HEART DISEASE & PREGNANCY.pptxHEART DISEASE & PREGNANCY.pptx
HEART DISEASE & PREGNANCY.pptx
 
Pregnancy and Heart Disease
Pregnancy and Heart DiseasePregnancy and Heart Disease
Pregnancy and Heart Disease
 
Cardiovascular Diseases on Pregnancy
Cardiovascular Diseases on PregnancyCardiovascular Diseases on Pregnancy
Cardiovascular Diseases on Pregnancy
 
cardiac disease in pregnancy
cardiac disease in pregnancycardiac disease in pregnancy
cardiac disease in pregnancy
 
Dr.avesta.2
Dr.avesta.2Dr.avesta.2
Dr.avesta.2
 

Mais de Dhritiman Chakrabarti

Inferential statistics quantitative data - single sample and 2 groups
Inferential statistics   quantitative data - single sample and 2 groupsInferential statistics   quantitative data - single sample and 2 groups
Inferential statistics quantitative data - single sample and 2 groupsDhritiman Chakrabarti
 
Inferential statistics quantitative data - anova
Inferential statistics   quantitative data - anovaInferential statistics   quantitative data - anova
Inferential statistics quantitative data - anovaDhritiman Chakrabarti
 
Types of variables and descriptive statistics
Types of variables and descriptive statisticsTypes of variables and descriptive statistics
Types of variables and descriptive statisticsDhritiman Chakrabarti
 
Study designs, randomization, bias errors, power, p-value, sample size
Study designs, randomization, bias errors, power, p-value, sample sizeStudy designs, randomization, bias errors, power, p-value, sample size
Study designs, randomization, bias errors, power, p-value, sample sizeDhritiman Chakrabarti
 
Bronchial blockers & endobronchial tubes
Bronchial blockers & endobronchial tubesBronchial blockers & endobronchial tubes
Bronchial blockers & endobronchial tubesDhritiman Chakrabarti
 
Bougie, trachlite , laryngeal tube , combitube , i gel ,truview
Bougie, trachlite , laryngeal tube , combitube , i gel ,truviewBougie, trachlite , laryngeal tube , combitube , i gel ,truview
Bougie, trachlite , laryngeal tube , combitube , i gel ,truviewDhritiman Chakrabarti
 
Autologous blood donation and transfusion
Autologous blood donation and transfusionAutologous blood donation and transfusion
Autologous blood donation and transfusionDhritiman Chakrabarti
 

Mais de Dhritiman Chakrabarti (20)

For crossover designs
For crossover designsFor crossover designs
For crossover designs
 
Logistic regression analysis
Logistic regression analysisLogistic regression analysis
Logistic regression analysis
 
Agreement analysis
Agreement analysisAgreement analysis
Agreement analysis
 
Linear regression analysis
Linear regression analysisLinear regression analysis
Linear regression analysis
 
Inferential statistics correlations
Inferential statistics correlationsInferential statistics correlations
Inferential statistics correlations
 
Inferential statistics quantitative data - single sample and 2 groups
Inferential statistics   quantitative data - single sample and 2 groupsInferential statistics   quantitative data - single sample and 2 groups
Inferential statistics quantitative data - single sample and 2 groups
 
Inferential statistics nominal data
Inferential statistics   nominal dataInferential statistics   nominal data
Inferential statistics nominal data
 
Inferential statistics quantitative data - anova
Inferential statistics   quantitative data - anovaInferential statistics   quantitative data - anova
Inferential statistics quantitative data - anova
 
Types of variables and descriptive statistics
Types of variables and descriptive statisticsTypes of variables and descriptive statistics
Types of variables and descriptive statistics
 
Data entry in Excel and SPSS
Data entry in Excel and SPSS Data entry in Excel and SPSS
Data entry in Excel and SPSS
 
Study designs, randomization, bias errors, power, p-value, sample size
Study designs, randomization, bias errors, power, p-value, sample sizeStudy designs, randomization, bias errors, power, p-value, sample size
Study designs, randomization, bias errors, power, p-value, sample size
 
Bronchospasm during induction
Bronchospasm during inductionBronchospasm during induction
Bronchospasm during induction
 
Bronchial blockers & endobronchial tubes
Bronchial blockers & endobronchial tubesBronchial blockers & endobronchial tubes
Bronchial blockers & endobronchial tubes
 
Brachial plexus block
Brachial plexus blockBrachial plexus block
Brachial plexus block
 
Bph
BphBph
Bph
 
Bougie, trachlite , laryngeal tube , combitube , i gel ,truview
Bougie, trachlite , laryngeal tube , combitube , i gel ,truviewBougie, trachlite , laryngeal tube , combitube , i gel ,truview
Bougie, trachlite , laryngeal tube , combitube , i gel ,truview
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusion
 
Autologous blood donation and transfusion
Autologous blood donation and transfusionAutologous blood donation and transfusion
Autologous blood donation and transfusion
 
Asa classification
Asa classificationAsa classification
Asa classification
 
Apu domas & carcinoid syndrome
Apu domas & carcinoid syndromeApu domas & carcinoid syndrome
Apu domas & carcinoid syndrome
 

Caeserean section complicated by mitral stenosis

  • 1. Presented by :- Dr Mangilal Moderator:- Dr AvnishBhardwaj
  • 2. Introduction  CARDIAC disease in pregnancy remains an important etiology of maternal ,fetal morbidity and mortality.  Mitral stenosis is the most commonly acquired valve lesion encountered in pregnant women and is almost invariably caused by RHD.  Pregnancy and the peripartum period worsen symptoms of cardiac disease.
  • 3. Presenting Complaints  A 37 year old woman presented at 28 weeks gestational age with inability to lie and became dyspneic even when speaking (class IV).  Had complete placenta previa, possible placenta accreta.
  • 4. Past History  Patient complained of dyspnea with moderate exertion before pregnancy( class II )  Past medical history – No history of TB, DM , HTN, Asthma,convulsion,chest pain  Drug history – no history of any drug allergy.  Family history- not significant
  • 5. Obs. history  Gravida 2, Para 1  Previous h/o Cesarean section delivery 16 yr earlier
  • 6. Clinical examination  Physical examination revealed an arterial blood pressure of 102/60 mmHg,  Regular heart rate of 108 beats/min,  Respiratory rate of 22 breaths/min.  There were diastolic(grade 2) and holosystolic( grade 3) apical murmurs.  The patient’s lungs were clear to auscultation bilaterally, and she had mild pedal edema.  Her symptoms improved with heart rate control using 25 mg metoprolol orally twice daily.
  • 7. Investigation  Electrocardiogram showed sinus tachycardia and left atrial enlargement.  Transthoracic echocardiogram revealed moderate to severe mitral stenosis, moderate to severe mitral regurgitation, and moderate pulmonary hypertension with estimated pulmonary artery systolic pressure of 54 mmHg. There was moderate tricuspid regurgitation.  Left and right ventricular systolic function were normal. PROVISIONAL DIAGNOSIS- PREGNANCY WITH MS
  • 8. Management  Cesarean section was planned at 36 weeks gestational age in a cardiac operating room with cardiopulmonary bypass capabilities on standby.
  • 9.  Prophylaxis against acid aspiration, 30 ml sodium bicitrate was administered orally in the holding area.  Patient was positioned in the left uterine displacement  Initial systemic arterial blood pressure was 125/65 (mean 76)mmHg. Her heart rate was 105 beats/min.  Remifentanil (0.2 ǔgm/kg/min) was started to attenuate the sympathetic response to laryngoscopy and intubation.
  • 10. Induction  Etomidate, and Succinylcholine was used for relaxant administered in a rapid sequence fashion. Maintenance  Remifentanil infusion(0.05– 0.1ug /kg/min),  Low level of Isoflurane(less than 0.5 minimum alveolar concentration),  Vecuronium for muscle relaxant.  Higher doses of inhalational agents were avoided to prevent uterine atony.  Depth of anesthesia was monitored using bispectral index values from 40–60 were maintained during the intraoperative period.  The patient was ventilated using 100% oxygen to maintain normocarbia.
  • 11.  Intra op monitoring by TEE ,Colour doppler  Three-dimensional ultrasound reconstruction of the mitral valve showed significant commissural fusion(mitral valve area 1.4cm2).  Cesarean section was performed without complications.  After delivery, 40 U oxytocin was administered intravenously in 2 hr.
  • 12. Initially monitored in the operating room after extubation to ensure normocarbia and stable pulmonary artery pressures.  Then transferred to the cardiac care unit for postoperative monitoring.  The patient was discharged from the cardiac care unit on postoperative day 1 and from the hospital on postoperative day 5.  She underwent mitral valve repair and tricuspid valve annuloplasty 4 months later.
  • 13. Heart disease with pregnancy  Epidemiology - incidence of cardiac disease in pregnant  0.2% to 3% of pregnancies are complicated by maternal heart disease in developed countries  Heart diseases are still the second most common non obstetrical cause of maternal mortality  Rheumatic heart disease accounts for majority of cases (~ 75%) in India while congenital heart disease are most common in developed countries -- Mitral stenosis is the most commonly acquired valve lesion in pregnant women and is almost caused by RHD.
  • 14. . RHD  Highly prevalent in developing countries.  India, the prevalence of RHD is 6:1,000 ( school- aged children)  Carditis occurs in 30–80% of patients with acute rheumatic fever, and at least 60% of untreated patients develop chronic RHD.
  • 15. Physiological changes - Consideration In Pregnancy The most important changes in cardiac function occurs in the first 8 weeks of pregnancy with maximum changes at 28 weeks ↓ Vascular resistance ↓ Blood pressure ↑ Heart rate ↑ Stroke volume ↑ CO ↑ Blood volume 30% - 50%
  • 16. The fall in the peripheral resistance is about 20-30% at 21-24 weeks & returns to normal at term. This fall is due to 1. The trophoblastic erosion of endometrial vessels, the placental bed serves as a large arteriovenous shunt causing lowered systemic vascular resistance 2. There is physiological vasodilatation which is believed to be secondary to endothelial prostacyclin and circulating progesterone. 3 .Anemia decreases blood viscosity with resultant decrease in systemic vascular resistance.
  • 19.
  • 20. Risk of haemodynamic stress  At the time of labor and delivery, pain and anxiety increase catecholamine release with resultant increases in heart rate, arterial blood pressure, and cardiac output.  Auto-transfusion of up to 500 ml with each contraction , increases preload and, hence cardiac output.  After delivery, there is an additional increase in venous return as a result of auto-transfusion from the contracting uterus as well as from the loss of foetal compression of the inferior vena cava.
  • 21. Features in Pregnancy which can mimic cardiac disease 1. Dyspnoea - due to hyperventilation, elevated diaphragm. 2. Pedal Edema 3. Cardiac impulse- Diffused and shifted laterally due to elevated diaphragm. 4. Jugular veins may be distended and JVP raised. 5. Systolic ejection murmurs along the left sternal border occur in 96% of pregnant women and are believed to be caused by increased flow across the aortic and pulmonary valves.
  • 22. Criteria to diagnose cardiac disease during pregnancy: 1.Presence of diastolic murmurs. 2.Systolic murmurs of severe intensity (grade III) 3.Unequivocal enlargement of heart (X-ray) 4.Presence of severe arrythmias, atrial fibrillation or flutter .
  • 23. Risk of cardiovascular complications during pregnancy Risk of cardiovascular complications during pregnancy High risk Low risk Intermediate risk of of of complications complications (≤ 1%) complications (5-15%) or death (≥25%)
  • 24.  Low risk of complications (≤ 1%):  Corrected tetralogy of fallot  Atrial septal defect  Ventricular septal defect  Patent ductus arteriosus  Mild pulmonic or tricuspid valve disease  Mitral stenosis (NYHA class I, II)  Mild regurgitant valve lesion  Bioprosthetic valve  Compensated heart failure (NYHA class I, II)
  • 25.  Intermediate risk of complications (5-15%):  Mechanical valve prosthesis  Aortic stenosis (mild to moderate)  Mitral stenosis with atrial fibrillation  Mitral stenosis (NYHA class III, IV)  Uncorrected cyanotic congenital heart disease (tetralogy of fallot)  Uncorrected coarctation of the aorta  Previous myocardial infarction
  • 26.  High risk of complications or death (≥25%):  Pulmonary hypertension (severe)  Eisenminger syndrome  Marfan disease with aortic root involvement  Peripartum cardiomyopathy  Severe aortic stenosis  NYHA class IV heart failure
  • 27. The indications for Termination of pregnancy 1. Eisenmenger’s syndrome. 2. Marfan’s syndrome with aortic involvement 3. Pulmonary hypertension. 4. Coarctation of aorta with valvular involvement.  Termination should be done before 12 weeks of pregnancy.
  • 28. The New York Heart Association (NYHA) Grading of functional capacity of the heart: No functional limitation of activity Symptoms with extra CLASS I ordinary physical work. Mild limitation of physical activity. Symptoms with ordinary CLASS II physical work Marked limitation of physical Symptoms with less than CLASS III activity ordinary physical work CLASS IV Severe limitation of physical Symptoms at rest activity
  • 29. Prognosis depends on the functional status  NYHA classes I and II lesions usually do well during pregnancy and have a favorable prognosis (mortality rate of <1%).  NYHA classes III and IV -mortality rate of 5% to 15%. These patients should be advised against becoming pregnant.
  • 30. Risk factors for cardiac failure during pregnancy  Infection  Anemia  Obesity  Hypertension  Hyperthyroidism  Multiple pregnancy
  • 31. Etiology The main cardiac diseases occuring with pregnancy are  Rheumatic heart disease  Congenital heart disease  Coronary heart disease  Cardiomyopathy
  • 32. Mitral stenosis  Most common manifestation of rheumatic heart disease  Incidence: ~ 90%  Symptoms develop ~ 30 years after rheumatic fever  Symptoms occur mitral valve orifice <2cm² (normal: 4-6 cm²)
  • 33. Mitral Stenosis:Pathophysiology  Normal valve area: 4-6 cm2  Mild mitral stenosis:  MVA 1.5-2.5 cm2  Minimal symptoms  Mod. mitral stenosis  MVA 1.0-1.5 cm2 usually does not produce symptoms at rest  Severe mitral stenosis  MVA < 1.0 cm2
  • 34. Mitral Stenosis: Symptoms  Breathlessness  Fatigue  Oedema, ascites  Palpitation  Haemoptysis  Cough  Chest pain  mitral facies or malar flush  Symptoms of thromboembolic complications (e.g. stroke, ischaemic limb)  Worsened by conditions that cardiac output. ◦ Exertion,fever, anemia, tachycardia,, pregnancy, thyrotoxicosis
  • 35. Signs of Mitral Stenosis Palpation:  Small volume pulse  Tapping apex-palpable S1  Palpable S2  Atrial fibrillation  Signs of raised pulmonary capillary pressure  Crepitations, pulmonary oedema, effusions  Signs of pulmonary hypertension  RV heave, loud P2 Auscultation:  Loud S1  S2 to OS interval inversely proportional to severity  Diastolic rumble: length proportional to severity  In severe MS with low flow- S1, OS & rumble may be inaudible
  • 36. Mitral Stenosis: Physical Examination S1 S2 OS S1 • First heart sound (S1) is loud and snapping • Opening snap (OS) • Low pitch diastolic rumble at the apex • Pre-systolic accentuation (esp. if in sinus rhythm)
  • 37. Mitral Stenosis: Complications  Atrial dysrrhythmias  Systemic embolization (10-25%) ◦ Risk of embolization is related to, age, presence of atrial fibrillation, previous embolic events  Congestive heart failure  Pulmonary infarcts (result of severe CHF)  Hemoptysis ◦ Massive: 20 to ruptured bronchial veins (pulmonary HTN) ◦ Streaking/pink froth: pulmonary edema, or infection  Endocarditis  Pulmonary infections
  • 39. Mitral stenosis:CXR  The cardiac size is Unequivocal  1. the left atrial appendage is prominent (LAA).  2. Main pulmonary artery (MPA) segment is just outside the left border, indicating pulmonary hypertension.  3. The enlargement of left pulmonary artery (LPA) and right pulmonary artery (RPA) are just modest, if at all.  4. The horizontal fissure is visible, indicating collection of edema fluid in the fissure.  5.The aortic knuckle (Ao) is also seen well.
  • 40. Mitral Stenosis:ECG  LAE  RVH  Premature contractions  Atrial flutter and/or fibrillation  freq. in pts with mod- severe MS for several years No P waves .  A fib develops in 30% to rhythm is irregularly irregular 40% of patients with symptoms right ventricular hypertrophy. Right axis deviation and deep S waves in the lateral leads. Combination of atrial fibrillation and right ventricular hypertrophy suggests mitral stenosis.
  • 41. Mitral Stenosis: Role of Echocardiography  Diagnosis of Mitral Stenosis  Assessment of hemodynamic severity ◦ mean gradient, mitral valve area, pulmonary artery pressure  Assessment of right ventricular size and function.  Assessment of valve morphology to determine suitability for percutaneous mitral balloon valvuloplasty  Diagnosis and assessment of concomitant valvular lesions  Reevaluation of patients with known MS with changing symptoms or signs.
  • 43. Mitral Stenosis:Therapy  Medical  Diuretics for LHF/RHF  Anticoagulation: In Atrial Fibrillation  AF requires aggressive treatment with digoxin and β-blockers . If pharmacotherapy fails, cardioversion should be performed. After cardioversion bed rest in left lateral position and diuretics should be given to ameliorates pulmonary oedema.  Endocarditis prophylaxis  β -blockers used to prevents tachycardia.  Propanolol can be administered without any adverse effect on foetus or neonate  Atenolol should be avoided in the early stages of pregnancy and only given with caution in the later stages because of its association with fetal growth retardation
  • 44. Surgical management » Before pregnancy- if significant MS is recognised before pregnancy : Surgery is recommended Mitral commisurotomy Mitral valve replacement – is preferred Bioprosthetic valve is preferred » During pregnancy- 1. Palliative Mitral Valvotomy : temporarily delays progression of MS and may enable successful completion of pregnancy. Best time is in 2nd trimester. 2. Mitral commisurotomy : in case of severe symptoms it can be performed at any stage of gestation. 3. Balloon Mitral Valvuloplasty : it is safe and effective in women with pliable valve .This circumvents open heart surgery and risks of anaesthesia and surgery for mother and foetus.
  • 45. Anaesthetic Goals:  Prevention of pain  Avoid tachycardia (diastolic filling time further decreased)  Events that increase the pulmonary vascular resistance like hypoxaemia, hypercarbia and acidosis should be avoided  Avoid increases in blood volume (result in pulmonary edema)  Avoid rapid and severe drop in SVR (compensatory increase in HR can lead to further decompensation)  Immediate treatment of acute atrial fibrillation
  • 46. The main principles of management with regard to valvular heart disease in Pregnancy • Early identification of the disease, and the assessment of the severity of the lesion. • High-risk lesions, for either mother or fetus, should be managed in a high care environment where invasive monitoring is possible, both pre- and post delivery. • Regional anaesthesia techniques in labour are an attractive option, and may be employed with good outcomes in many patients. • Carefully titrated epidural anaesthesia for labour is associated with less sympathetic blockade than spinal or epidural anaesthesia for caesarean delivery. • Severe mitral or aortic stenosis, or any valvular heart condition associated with pulmonary oedema or heart failure, are contraindications to regional anaesthesia.
  • 47. Anaesthetic Options VAGINAL DELIVERY :  The role of the anaesthesiologist begins by providing good labour analgesia.  Epidural anaesthesia is recommended, unless obstetrically contraindicated.  Caesarean section is indicated for OBSTETRIC REASONS ONLY.  Tachycardia, secondary to labour pain, increases flow across the mitral valve, producing sudden rises in left atrial pressure, leading to acute pulmonary oedema. This tachycardia is averted by epidural analgesia without significantly altering the patient haemodynamics.
  • 48. Mitral stenosis : Regional Anaesthesia  I stage of labour : MS does not change management-adequate analgesia is essential to minimize tachycardia. Epidural analgesia is effective. Adequate hydration should be maintained. Intrathecal opioid such as Fentanyl 25 μg produces good analgesia without major haemodynamic changes.  II stage of labour : Minimize maternal expulsive efforts, allowing fetal descent to be accomplished by uterine contractions. This is to avoid the deleterious effects of the Valsalva maneuver, which causes an undesirable increase in venous return.  Intrathecal opioid with low dose LA can be given for analgesia and anaesthesia. The 2nd stage should be cut short by instrumentation.  LA to provides perineal anaesthesia
  • 49. • CSE : intrathecal opioid +/- small dose of LA followed by slow epidural infusion of a dilute solution of LA +/- opioid. (0.125% bupivacaine + 2µg/ml fentanyl). • Epinephrine should be avoided as it may induce tachycardia. • Phenylephrine- vesopressor of choice (no tachycardia) • Invasive cardiac monitoring like radial artery cannulation and pulmonary catheter are beneficial in assessing the cardiac output, pulmonary artery pressure and for guiding fluid and drug therapy, especially in NYHA III and IV patients. • Foetal heart rate monitoring should be carried out during all stages of labour. • Pulse oximetry monitoring is mandatory. • Supplementary epidural anaesthesia can be maintained throughout the immediate post-partum period and the catheter left in situ could provide anaesthesia for immediate or post-partum tubal sterilization.
  • 50. CAESAREAN-SECTION  General anaesthesia NYHA class 3 and 4 patients .  Regional anaesthesia is preferred over general anaesthesia in NYHA class 1 and2 patients – Regional : Spinal & Epidural Epidural anaesthesia - preferred over spinal anaesthesia :  More predictability and control over hemodynamic changes.  maintains systemic vascular resistance.  gradual onset of sympathetic block  Slower induction of anaesthesia and ensures maternal hemodynamic stability.
  • 51. Mitral stenosis:GA  General anaesthesia has the disadvantage of increased Pulmonary Arterial pressure and tachycardia during laryngoscopy and tracheal intubation.  Premedication : sedative and anxiolytics are avoided.  Only counseling done to alleviate the anxiety.  Preoxygenation:done with 100% o2 for 5 min.  Induction :Inj. Thiopentone 3-4 mg/kg  Intubation: Inj.succinylcholine 1-1.5mg/kg  Maintained with opioids, neuromuscular blockers, nitrous oxide, and oxygen.  A beta-adrenergic receptor antagonist, fentanyl, I.v xylocard should be administered before or during the induction of anaesthesia to blunt intubation response.  The adverse effects of positive-pressure ventilation on the venous return may ultimately leads to cardiac failure.
  • 52. Continued……  Tachycardia inducing drugs like atropine, ketamine, pancuronium and meperidine, should be totally avoided.  Esmolol has a rapid onset and short duration of action, it is a better choice in controlling tachycardia.  Modified rapid sequence induction using etomidate, remifentanyl and succinylcholine is an ideal choice in tight stenosis with pulmonary hypertension. General anesthesia provides the advantages of definitive airway control and the ability to use transesophageal echocardiographic monitoring throughout the procedure. Higher doses of inhalational agents should be avoided to prevent uterine atony. •Emergence must be carefully controlled to ensure avoidance of tachycardia
  • 53. Continued……  Diuretics should also be used cautiously because hypovolemia can impair fetal blood supply  Reversal: Avoid tachycardia, extubation is done when patient is fully awake.  After delivery oxytocin should be administered as intravenous infusion preferably slowly. Stat i.v dosing should be avoided  These Patients are at risk for haemodynamic compromise and pulmonary oedema during postpartum period,so require ICU care.  For postoperative analgesia :I.V opioid or NSAIDS
  • 54. Conclusion  Irrespective of the mode of delivery and anaesthetic technique, these patients are at a great risk of haemodynamic stress due to autotransfusion of blood from the uterus. This may lead to pulmonary hypertension, pulmonary oedema and cardiac failure. Therefore, intensive monitoring and therapy should be continued till the haemodynamic parameters return to normal.  As a rule, regurgitant valvular lesions are far better tolerated in pregnancy than are stenotic lesions. .  Patients with severe symptomatic valvular heart disease should ideally be counselled against pregnancy.  In the event of pregnancy, early consultation between obstetrician and anaesthesiologist allows for planning with regards to both the timing of delivery and optimal analgesia/ anaesthesia.